Download full announcement RenalytixAI Expands Leadership Team with Focus on Reimbursement ahead of roll-out of artificial intelligence clinical in vitro diagnostic KidneyIntelX ™ RenalytixAI plc (AIM: RENX), a developer of... read more →
Download full announcement Renalytix AI welcomes US Administration’s dedication to advancing American kidney health Renalytix AI plc (AIM: RENX), a developer of artificial intelligence enabled clinical diagnostics for kidney disease,... read more →
Download full announcement Data development plan review continues with FDA under Breakthrough Device Designation Process Performance meets or exceeds targets for identifying Rapid Kidney Function Decline in patients with Type... read more →
Download full announcement Published data on blood diagnostic for subclinical acute kidney transplant rejection and potential to tailor immunosuppressive therapy Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled... read more →
Download full announcement CPT Code a key component for reimbursement from private medical insurance and Medicare Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney... read more →
Download full announcement Demonstrates ability to predict early rejection in kidney transplant Supports successful development of a predictive blood test for transplant patients Renalytix AI plc (AIM: RENX), a developer... read more →
Download full announcement High quality production-scale batches of critical materials successfully produced Key milestone achieved for scaled commercial test production Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled... read more →
Download full announcement Renalytix AI plc(AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces that the New York State Department of Health has issued a Clinical... read more →
Download full announcement Investigators now include transplant experts from University of Oxford, Yale School of Medicine, Emory University School of Medicine, Icahn School of Medicine at Mount Sinai, University of... read more →
Download full announcement Renalytix AI plc (AIM: RENX), a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, announces a collaboration with University Medical Center Groningen (UMCG), Netherlands, to evaluate... read more →